Basic information Safety Supplier Related

3-Iodo-7-aza-1H-azaindazole

Basic information Safety Supplier Related

3-Iodo-7-aza-1H-azaindazole Basic information

Product Name:
3-Iodo-7-aza-1H-azaindazole
Synonyms:
  • 3-Iodo-7-aza-1H-azaindazole
  • 3-iodo-1H-pyrazolo[3,4-b]pyridine
  • 3-Iodo-
  • 3-Iodo-1H-pyrazolo[3,4-b]...
  • 1H-Pyrazolo[3,4-b]pyridine, 3-iodo-
  • 3-Iodo-7-aza-1H-indazole
  • 3-iodo-2H-pyrazolo[3,4-b]pyridine
  • 3-Iodopyrazolo[3,4-b]pyridine
CAS:
117007-52-0
MF:
C6H4IN3
MW:
245.02
Product Categories:
  • Aromatics
  • Heterocycles
Mol File:
117007-52-0.mol
More
Less

3-Iodo-7-aza-1H-azaindazole Chemical Properties

Melting point:
177-179°C
Boiling point:
379.8±22.0 °C(Predicted)
Density 
2.219±0.06 g/cm3(Predicted)
storage temp. 
Keep in dark place,Inert atmosphere,2-8°C
solubility 
Chloroform, DMSO
form 
Solid
pka
7.96±0.40(Predicted)
color 
Pale Yellow
InChI
InChI=1S/C6H4IN3/c7-5-4-2-1-3-8-6(4)10-9-5/h1-3H,(H,8,9,10)
InChIKey
TYXAGVKIICJXGF-UHFFFAOYSA-N
SMILES
C12NN=C(I)C1=CC=CN=2
More
Less

Safety Information

Risk Statements 
36/37/38
Safety Statements 
26-37/39
RIDADR 
UN2811
HS Code 
2933399990
More
Less

3-Iodo-7-aza-1H-azaindazole Usage And Synthesis

Chemical Properties

Pale Yellow Solid

Uses

3-Iodo-7-aza-1H-azaindazole is used for preparation of azaindazole compounds as CCR1 antagonists.

Synthesis

271-73-8

117007-52-0

General procedure for the synthesis of 3-iodo-1H-pyrazolo[3,4-b]pyridine from 1H-pyrazolo[3,4-b]pyridine: 1H-pyrazolo[3,4-b]pyridine (0.50 g, 4.2 mmol), iodine (2.1 g, 8.3 mmol), 3M aqueous NaOH (20 mL) and 1,4-dioxane (20 mL) were added to a reaction flask . The reaction mixture was heated to 55 °C and stirred overnight. Upon completion of the reaction, the organic solvent was evaporated under reduced pressure. Subsequently, acetic acid was added dropwise to the residue and the pH of the solution was adjusted to 5. A yellow solid was precipitated. The precipitate was collected by filtration and dried in air to afford the target product 3-iodo-1H-pyrazolo[3,4-b]pyridine (0.93 g, 90% yield). The structure of the product was confirmed by 1H NMR (400 MHz, CDCl3) δ 13.80 (br s, 1H), 8.66 (d, J=4.8 Hz, 1H), 7.88 (d, J=7.2 Hz, 1H), 7.26 (dd, J=7.2, 4.8 Hz, 1H) and MS (ESI) m/z: 246 (M+H)+.

References

[1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 5, p. 1243 - 1245
[2] Patent: WO2006/130673, 2006, A1. Location in patent: Page/Page column 86
[3] European Journal of Medicinal Chemistry, 2013, vol. 68, p. 361 - 371
[4] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 13, p. 4763 - 4772
[5] Patent: WO2016/97918, 2016, A1. Location in patent: Page/Page column 51-52

3-Iodo-7-aza-1H-azaindazoleSupplier

Xinyi Guangbang Medical Technology Co., Ltd. Gold
Tel
13361936468
Email
410756539@qq.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Email
chenyj@titansci.com
ZEROSCHEM.CO.,LTD.
Tel
10-61256048 13810278579
Email
sales@zeroschem.com